Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
about
Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patientsPrognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer: A Systematic Review and Meta-analysisInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisNanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinomaPrognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysisThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentImmunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?Neutrophil to lymphocyte ratio predicts persistent organ failure and in-hospital mortality in an Asian Chinese population of acute pancreatitis.Predictive Value of Preoperative Neutrophil Lymphocyte Ratio in Determining the Stage of Gastric Tumor.Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study.Immunity and immune suppression in human ovarian cancer.The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysisPre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patientsNeutrophil count is associated with survival in localized prostate cancerPancreatic ductal adenocarcinoma: a review of immunologic aspects.Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective studyPrognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.Advances in biomarker research for pancreatic cancer.The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinomaNeutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severityPretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram.The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapyNeutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib.Inflammation in malignant mesothelioma - friend or foe?Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinomaPre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapyThe neutrophil-to-lymphocyte ratio: a narrative reviewNeutrophils: important contributors to tumor progression and metastasis.Prognostic significance of neutrophil-lymphocyte ratios in large cell neuroendocrine carcinoma.Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma.The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.Incorporation of NLR into NIH stratification system increases predictive accuracy for surgically resected gastrointestinal stromal tumors.
P2860
Q24568136-0D2AC66F-7F30-4BDF-B787-4E6ECA7BDB4AQ26773406-5480F0F0-6D98-4B03-A3E3-8783A15FA4C2Q27009534-E7A60D13-AB74-47F0-8810-2D30BB5BDA74Q27022482-272A329A-E0B3-4D35-BBB5-8AF92E856606Q28077206-BC174E23-DA55-4817-A84A-1D9DB5E4FA1BQ28083684-C83EDD32-6D7B-4CF3-9611-FF541CE0F5C0Q28241308-4D5995AC-56E5-4076-9271-5922EE536805Q33357295-EF7D691B-555D-4710-81B1-DDEB82137EFAQ33595219-85342088-E000-4D1B-834F-0499B7A8A664Q33627306-0E10E20B-E7D8-4096-8470-098AD3118468Q33762053-B55563A7-39CA-4213-B865-DA2D3E7848C9Q35131890-7BCDDF9F-A96C-49B9-9FC8-B8E701FB8E39Q35138135-DD3E6816-2394-4945-8EEF-CA55756B9B85Q35274955-21004FAF-4029-48A7-AAFA-9E4CF091CEFFQ35424504-F176AC8D-F2C7-4A89-A28B-969A7DDA71BCQ35595696-772C8186-CC2C-4ADD-B3E5-5A0E493434C3Q35751637-2CE60CB4-8EC4-4F4E-B09C-0F6E2BA54B6AQ35870682-F75281E3-3FFB-4209-B6FE-7C52E79EAFB5Q35905137-ADB06897-AE70-4B0C-99E8-774800520214Q35905788-17E4EFE9-2477-4952-B897-357D37F82946Q36126609-1938C683-5828-4398-BCE3-29BDA3AF6C5BQ36353298-ADDD1964-F612-4C3B-85C7-32D242646B91Q36464626-FDA1B398-FA5D-442C-9E00-BB6300154C6EQ36483161-A28C297F-92BB-43E3-84AB-F3B998FA6914Q36569129-648C17DB-F24A-4769-A3D7-3E8F39860E7BQ36824972-BEE01283-9A76-49A3-BF42-97F21A380BACQ37031596-BA365C8D-1576-409A-86F7-3C027DC67640Q37089422-8FBD3B18-38D4-4E29-B836-241F5236A60EQ37090789-A85DF5B2-714D-4FDD-A31E-1E636B3757B8Q37214300-8C7A4057-B693-4A83-997D-92BF20D87AAFQ37223578-64D320FD-20DE-4DFD-BE2E-D6F6BACCFE02Q37295840-9E1E1BE9-C2AA-43BE-879B-DF3E5DB71407Q37573454-9E9D4AAF-7A1D-414A-84DD-C9BE69331774Q38585102-852D79C9-8F8C-4BE0-8F49-F6F8CF4E3109Q38647526-17C04AB1-D502-45E4-B045-F23540133312Q38735885-F8FB1D57-3A3D-4E92-AE50-DA6254420816Q38806901-21F1B739-56F7-4241-838C-87FD2A2F7F4AQ38980174-1EDD2405-D9D1-470F-AEE8-5075DAA2BFFAQ39041165-4041E874-FA6B-4DA7-A159-42D9EFD2FD34Q39049191-3B3A9426-CFB2-4F72-B9FB-75DDE2DF69CA
P2860
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
@en
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
@nl
type
label
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
@en
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
@nl
prefLabel
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
@en
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
@nl
P2093
P2860
P1433
P1476
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.
@en
P2093
Feng-Hua Wang
Pei-Rong Ding
Rui-Hua Xu
Wen-Qi Jiang
Yan-Xia Shi
You-Jian He
Yu-Hong Li
Zhi-Qiang Wang
P2860
P304
P356
10.3109/1354750X.2010.491557
P577
2010-09-01T00:00:00Z